Drug Profile


Alternative Names: Bextra; Kudeq; SC 65872; Vah; Valdyn; Valus; Vorth; YM 974

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Pfizer
  • Developer Astellas Pharma; Pfizer
  • Class Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Market Withdrawal Dysmenorrhoea; Osteoarthritis; Pain; Rheumatoid arthritis
  • Discontinued Migraine

Most Recent Events

  • 18 May 2005 Withdrawn for Dysmenorrhoea in Brazil (PO)
  • 18 May 2005 Withdrawn for Osteoarthritis in Brazil (PO)
  • 18 May 2005 Withdrawn for Pain in India (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top